Press Releases

DURHAM, NC, and LIEGE, BELGIUM - November 29, 2010 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that it has granted a non-exclusive worldwide license for its patented methylation specific PCR (MSP)...

Read More...

DURHAM, NC, LIEGE, BELGIUM and LEXINGTON, MA - November 22nd, 2010 - MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that it has agreed to out-license certain DNA methylation biomarkers to Predictive...

Read More...

DURHAM, NC, and LIEGE, BELGIUM - November 4, 2010 - MDxHealth SA (NYSE Euronext Brussels & Amsterdam: MDXH), a leading molecular diagnostics company focused on personalized medicine in the field of cancer, today issued its business update for the quarter ended September 30, 2010. ...

Read More...

Focus on molecular diagnostic testing for personalized medicine in oncology   DURHAM, NC, and LIEGE, BELGIUM - October 19, 2010 - MDxHealth (NYSE Euronext: MDXH), a leading molecular diagnostics company, formerly known as OncoMethylome Sciences, today announced further details regarding its...

Read More...

* { font-family: Arial, Verdana, Helvetica; font-size: 13px;} td { padding: 3px; } } DURHAM, NC, and LIEGE, BELGIUM - October 6, 2010 - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) today announced that its Extraordinary General Shareholders' Meeting passed the...

Read More...

DURHAM, NC, and LIEGE, BELGIUM - September 28, 2010 - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) today announced the appointments of Dr. Melissa A. Thompson as Vice President Regulatory Affairs and Quality Assurance, and of Mr. Christopher (Chris) Thibodeau as...

Read More...

DURHAM, the United States, and LIEGE, BELGIUM - September 23rd, 2010 - OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, announced today that it has entered into an agreement with GlaxoSmithKline Biologicals S.A. (GSK) for the...

Read More...

DURHAM, NC, and LIEGE, BELGIUM - August 26, 2010 - OncoMethylome Sciences (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, announced today its 2010 half-year results and its new strategy.   Highlights   -     ...

Read More...

Madison, Wis. and Liege, Belgium, July 27, 2010 - 7:30 EDT - Exact Sciences Corp. (Nasdaq: EXAS) and OncoMethylome Sciences S.A. (Euronext Brussels: ONCOB) today announced that they have entered into a license agreement under which Exact Sciences has obtained exclusive, worldwide rights to up...

Read More...

Durham (NC, USA) and Liege (Belgium) - June 22, 2010, 18:00 CET - OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) reports that as of June 14, 2010, ING Investment Management Luxembourg SA's shareholding is 4.95% of the total 13,185,614 outstanding shares of the...

Read More...

Pages